A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers
Hisao Asamura(Keio University), Etsuo Miyaoka(Tokyo University of Science), Masaki Mori(Tokai University), Tomoyuki Goya(Kyorin University), Kenji Eguchi(Daido Steel (Japan)), Yasunori Sohara(Jichi Medical University), Ryosuke Tsuchiya(Tokyo National Hospital), Hiroshi Inoué(Tokai University), Toshihiro Nukiwa(Tohoku University), Yoshihiko Koshiishi(Kyorin University), Y. Nakanishi(Kyushu University), Kaoru Shimokata(Nagoya University)
Cited by 424
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953